The Food and Drug Administration is reviewing a request for new warnings on antidepressant drugs, and that's presenting an unusual conflict of interest at the agency.
Experts fear a new FDA warning could cause pregnant women to stop medication unnecessarily, leading to serious health risks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results